NYSE:ABT - Abbott Laboratories Stock Price, Forecast & News

Abbott Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABT."

Abbott Laboratories declared a quarterly dividend on Monday, February 3rd. Shareholders of record on Friday, February 7th will be given a dividend of $0.08 per share on Friday, February 28th. This represents a $0.32 annualized dividend and a yield of 0.36%. View Abbott Laboratories' Dividend History.

Abbott Laboratories (NYSE:ABT) announced its earnings results on Wednesday, January, 22nd. The healthcare product maker reported $0.95 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.95. The healthcare product maker had revenue of $8.31 billion for the quarter, compared to the consensus estimate of $8.26 billion. Abbott Laboratories had a return on equity of 18.34% and a net margin of 11.56%. The business's revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.81 EPS. View Abbott Laboratories' Earnings History.

Abbott Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, April 15th 2020. View Earnings Estimates for Abbott Laboratories.

Abbott Laboratories issued an update on its FY20 earnings guidance on Wednesday, January, 22nd. The company provided EPS guidance of $3.55-3.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.60.

18 Wall Street analysts have issued 12 month price targets for Abbott Laboratories' shares. Their forecasts range from $81.00 to $105.00. On average, they expect Abbott Laboratories' stock price to reach $95.79 in the next year. This suggests a possible upside of 6.8% from the stock's current price. View Analyst Price Targets for Abbott Laboratories.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Abbott Laboratories in the last year. There are currently 2 sell ratings, 4 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Abbott Laboratories.

Headlines about ABT stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Abbott Laboratories earned a news impact score of 1.8 on InfoTrie's scale. They also gave media coverage about the healthcare product maker a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Abbott Laboratories.

Some companies that are related to Abbott Laboratories include Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), Hologic (HOLX), ABIOMED (ABMD), Hill-Rom (HRC), Globus Medical (GMED), Integra Lifesciences (IART), CONMED (CNMD), ProShares UltraShort DJ-UBS Commodity (CMD), Synthorx (THOR) and AtriCure (ATRC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Abbott Laboratories investors own include AbbVie (ABBV), AT&T (T), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Home Depot (HD), NVIDIA (NVDA), Walt Disney (DIS), Verizon Communications (VZ), Pfizer (PFE) and Intel (INTC).

Abbott Laboratories' stock is owned by many different of retail and institutional investors. Top institutional shareholders include State Street Corp (4.16%), Massachusetts Financial Services Co. MA (1.75%), FMR LLC (1.41%), Bank of New York Mellon Corp (1.18%), UBS Asset Management Americas Inc. (0.56%) and Franklin Resources Inc. (0.53%). Company insiders that own Abbott Laboratories stock include Andrea F Wainer, Andrew H Lane, Brian B Yoor, Brian J Blaser, Daniel Gesua Sive Salvadori, Daniel J Starks, Hubert L Allen, Jaime Contreras, Jared Watkin, John G Stratton, John M Capek, Joseph J Manning, Michael J Pederson, Miles D White, Randel William Woodgrift, Roger Bird, Sally E Blount, Sharon J Bracken and Stephen R Fussell. View Institutional Ownership Trends for Abbott Laboratories.

ABT stock was sold by a variety of institutional investors in the last quarter, including Fred Alger Management LLC, FIL Ltd, FMR LLC, Thrivent Financial for Lutherans, Massachusetts Financial Services Co. MA, Bank of New York Mellon Corp, UBS Asset Management Americas Inc. and AQR Capital Management LLC. Company insiders that have sold Abbott Laboratories company stock in the last year include Andrea F Wainer, Brian B Yoor, Brian J Blaser, Daniel Gesua Sive Salvadori, Hubert L Allen, Jaime Contreras, Jared Watkin, John M Capek, Joseph J Manning, Michael J Pederson, Miles D White, Randel William Woodgrift, Roger Bird, Sally E Blount, Sharon J Bracken and Stephen R Fussell. View Insider Buying and Selling for Abbott Laboratories.

ABT stock was purchased by a variety of institutional investors in the last quarter, including Polen Capital Management LLC, State Street Corp, GQG Partners LLC, Milestone Resources Group Ltd, Johanson Financial Advisors Inc., Amundi Pioneer Asset Management Inc., Marshall Wace LLP and Toronto Dominion Bank. Company insiders that have bought Abbott Laboratories stock in the last two years include Daniel J Starks, John G Stratton and Randel William Woodgrift. View Insider Buying and Selling for Abbott Laboratories.

Shares of ABT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ABT stock can currently be purchased for approximately $89.66.

Abbott Laboratories has a market capitalization of $158.56 billion and generates $31.90 billion in revenue each year. The healthcare product maker earns $3.69 billion in net income (profit) each year or $3.24 on an earnings per share basis. Abbott Laboratories employs 103,000 workers across the globe.View Additional Information About Abbott Laboratories.

The official website for Abbott Laboratories is http://www.abbott.com/.

Abbott Laboratories' mailing address is 100 ABBOTT PARK ROAD D-322 AP6D, ABBOTT PARK IL, 60064. The healthcare product maker can be reached via phone at 224-667-6100.